Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma × Sunitinib × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 56 Breast Neoplasms 19 Kidney Neoplasms 16 Gastrointestinal Stromal Tumors 14 Neoplasms 12 Carcinoma, Non-Small-Cell Lung 9 Prostatic Neoplasms 8 Urinary Bladder Neoplasms 7 Neoplasm Metastasis 6 Colorectal Neoplasms 6 Brain Neoplasms 5 Thyroid Neoplasms 4 Stomach Neoplasms 4 Small Cell Lung Carcinoma 4 Ovarian Neoplasms 4 Neuroendocrine Tumors 4 Liver Neoplasms 4 Carcinoma, Hepatocellular 4 Carcinoma 4 Thyroid Cancer, Papillary 3 Sarcoma 3 Leukemia, Myelomonocytic, Chronic 3 Kidney Diseases 3 Glioblastoma 3 Esophageal Neoplasms 3 Clear-cell metastatic renal cell carcinoma 3 Astrocytoma 3 Adenoma, Islet Cell 3 Adenocarcinoma, Follicular 3 Urogenital Neoplasms 2

Interventions

Gemcitabine 11 Cisplatin 11 Capecitabine 11 Oxaliplatin 9 Fluorouracil 9 130-nm albumin-bound paclitaxel 8 pembrolizumab 7 Paclitaxel 7 Ramucirumab 6 Leucovorin 6 Carboplatin 6 Bevacizumab 6 Pemetrexed 4 Nivolumab 4 Irinotecan 4 Everolimus 4 Erlotinib Hydrochloride 4 Docetaxel 4 Cyclophosphamide 4 Albumin-Bound Paclitaxel 4 trastuzumab deruxtecan 3 Radiotherapy 3 Afatinib 3 zolbetuximab 2 pralsetinib 2 cabozantinib 2 Trastuzumab 2 Ipilimumab 2 vosaroxin 1 vandetanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡